Complete Conference Management San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians 2025

• Target Audience: cardiologists, internists, primary care physicians
• Sample video: contact me for sample video
• Information:

The Symposium combines didactic talks, panel discussions, case presentations and patient perspectives to provide a full and balanced overview of relevant management issues. The four highly focused sessions that comprise this year’s Symposium will cover topics related to Populations and Patients at Risk (Session I), Amyloid Heart Disease, Infiltrative Heart Disease, Hypertrophic and Other Forms of Inherited Cardiomyopathy (Session II), Identifying and Treating Heart Failure (Session III), Cardiogenic Shock, Percutaneous Devices to Support Cardiac Function, Emerging Strategies for Preventing Sudden Cardiac Death and Advances in Catheter Based Treatment of Atrial Fibrillation and Valvular Disease (Session IV). During each session, the audience will have an opportunity to comment on the talks and question the faculty on their thoughts about the best approaches for patient management. Our goal, as always, is to provide cutting edge information in a format that will enhance adaption of the knowledge that is gained into clinical practice.

Learning Objectives

At the conclusion of this activity, participants should be able to:

Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.

Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.

Target Audience

This course is designed for cardiologists, internists, primary care physicians, nurses, PA’s, PharmD’s and all other allied healthcare professionals with an interest in heart failure.

• Topics:

01 Identifying Patients at Risk for Developing Heart Failure

02 Using SGLT inhibitors to Prevent CV Disease and Heart Failure

04 Identifying and Treating Patients with Dyslipidemia

05 Use of Non-Steroidal MRAs To Prevent CV Disease, CKD and Heart Failure

06 Identifying Patients at Risk for Cardiac Toxicity from Chemotherapy – Update on How to Monitor and Preventive Strategies

07 Reducing Cardiovascular Risk in Our Patients- Case Presentation and Panel Discussion

08 Recognizing and Treating Patients with Amyloidosis

09 Cardiac Myosin Inhibitors and Other New Treatment Options for Patients with Hypertrophic Cardiomyopathy

10 Identifying and Treating Sarcoidosis and Other Infiltrative Diseases That Cause Heart Failure

11 Gene Therapy for Monogenic Causes of Heart Failure and Other Cardiovascular Disease

12 Pulmonary Arterial Hypertension (PAH)

13 Heart Failure Management in Adult Congenital Heart Disease

14 Peripartum Cardiomyopathy

15 Case Presentation and Panel Discussion

16 Coffee and Master Class on Physical Diagnosis

17 Monitoring Devices To Identify and Treat Congestion

18 Treating Patients with HFrEF-The Four Pillars of Therapy

19 Adjunctive Medical Therapy for Treating Patients with HFrEF

20 Treating Patients with HFpEF – How Do the Experts Do It

21 Using Biomarkers To Identify and Manage Heart Failure

22 Novel Approaches for Recognizing and Treating Congestion

23 How to Talk So Patients with Listen How to Listen So Patients Will Talk

24 Case Presentation

25 Identifying and Treating Cardiogenic Shock

26 Percutaneous Devices for Temporary Support of Cardiac Function

27 Catheter Based Treatments of Valvular Heart Disease

28 Left Atrial Occlusion Devices for Preventing Thromboemboli Complications of Atrial Fibrillation

29 Advances in Preventing Sudden Cardiac Death in Patients with Heart Failure

30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes

30 Stage D Heart Failure and Available Treatment Options to Improve Outcomes

31 Palliative and Hospice Care for Patients with Advanced Heart Failure

SDHF Winter Symposium 2025.pdf